FTC Tells High Court To Nix Boehringer's Appeal In Doc Row
The Federal Trade Commission has urged the Supreme Court to deny an appeal by Boehringer Ingelheim Pharmaceuticals, which contends that work product protections were cut in a fight over access to...To view the full article, register now.
Already a subscriber? Click here to view full article